BACKGROUND: Kinins are modulators of cardiovascular function. After ischemic injury, enhanced kinin generation may contribute in processes responsible for tissue healing. METHODS AND RESULTS: Using pharmacological and genetic approaches, we investigated the role of kinin B(1) receptor in reparative angiogenesis in a murine model of limb ischemia. The effect of B(1) pharmacological manipulation on human endothelial cell proliferation and apoptosis was also studied in vitro. Abrogation of B(1) signaling dramatically inhibited the native angiogenic response to ischemia, severely compromising blood perfusion recovery. Outcome was especially impaired in B(1) knockouts that showed a very high incidence of limb necrosis, eventually leading to spontaneous auto-amputation. Conversely, local delivery of a long-acting B(1) receptor agonist enhanced collateral vascular growth in ischemic skeletal muscle, accelerated the rate of perfusion recovery, and improved limb salvage. In vitro, B(1) activation stimulated endothelial cell proliferation and survival, whereas B(1) antagonism induced apoptosis. CONCLUSIONS: Our results indicate that the B(1) plays an essential role in the host defense response to ischemic injury. B(1) signaling potentiation might be envisaged as a utilitarian target for the treatment of ischemic vascular disease.
BACKGROUND: Kinins are modulators of cardiovascular function. After ischemic injury, enhanced kinin generation may contribute in processes responsible for tissue healing. METHODS AND RESULTS: Using pharmacological and genetic approaches, we investigated the role of kinin B(1) receptor in reparative angiogenesis in a murine model of limb ischemia. The effect of B(1) pharmacological manipulation on human endothelial cell proliferation and apoptosis was also studied in vitro. Abrogation of B(1) signaling dramatically inhibited the native angiogenic response to ischemia, severely compromising blood perfusion recovery. Outcome was especially impaired in B(1) knockouts that showed a very high incidence of limb necrosis, eventually leading to spontaneous auto-amputation. Conversely, local delivery of a long-acting B(1) receptor agonist enhanced collateral vascular growth in ischemic skeletal muscle, accelerated the rate of perfusion recovery, and improved limb salvage. In vitro, B(1) activation stimulated endothelial cell proliferation and survival, whereas B(1) antagonism induced apoptosis. CONCLUSIONS: Our results indicate that the B(1) plays an essential role in the host defense response to ischemic injury. B(1) signaling potentiation might be envisaged as a utilitarian target for the treatment of ischemic vascular disease.
Authors: Mehmet Bilgin; Christiane Neuhof; Oliver Doerr; Utz Benscheid; Sheila S Andrade; Astrid Most; Yaser Abdallah; Mariana Parahuleva; Dursun Guenduez; Maria L Oliva; Ali Erdogan Journal: J Physiol Biochem Date: 2010-08-02 Impact factor: 4.158
Authors: Adam R Wende; Jamie Soto; Curtis D Olsen; Karla M P Pires; John C Schell; Frederic Larrieu-Lahargue; Sheldon E Litwin; Masao Kakoki; Nobuyuki Takahashi; Oliver Smithies; E Dale Abel Journal: Endocrinology Date: 2010-05-25 Impact factor: 4.736
Authors: Markus Magerl; Michael Bader; Anne Gompel; Kusumam Joseph; Allen P Kaplan; Georg Kojda; Thomas Renné; Markus Wirth; Marcus Maurer; Martin K Church Journal: Inflamm Res Date: 2013-12-08 Impact factor: 4.575
Authors: Vanessa F Merino; Mihail Todiras; Luciana A Campos; Vera Saul; Elena Popova; Ovidiu C Baltatu; João B Pesquero; Michael Bader Journal: J Mol Med (Berl) Date: 2008-04-19 Impact factor: 4.599
Authors: M E Marketou; J Kontaraki; E Zacharis; F Parthenakis; S Maragkoudakis; I Gavras; H Gavras; P E Vardas Journal: J Hum Hypertens Date: 2014-01-09 Impact factor: 3.012
Authors: Nicolle Kränkel; Stephen Paul Armstrong; Craig Alexander McArdle; Colin Dayan; Paolo Madeddu Journal: PLoS One Date: 2010-06-17 Impact factor: 3.240